Valantine Hannah
SEC CIK 1855608 · EDGAR
BoughtSold
Most active insiders at CDNA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hanna John Walter JR | Pres, CEO, Dir | — | $7.54M |
| 2 | Goldberg Michael | Dir | — | $2.10M |
| 3 | Valantine Hannah | Dir | — | $1.32M |
| 4 | Bickerstaff George | Dir | — | $925.7K |
| 5 | COURNOYER CHRISTINE | Dir | — | $751.0K |
| 6 | Novack Jeffrey Adam | GC, Sec | — | $452.8K |
| 7 | TORRES ARTHUR A | Dir | — | $214.7K |
| 8 | Gunasekaran Suresh | Dir | — | — |
| 9 | SMITH NATHAN | CFO | — | — |
| 10 | Meng Jessica | Chief Commercial Off | — | — |
Transactions 44
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-17 16:22 | 2026-07-16 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | M - OptEx | $14.76 | +28.8K | 65.5K | +78% | +$424.9K |
| DMT | 2026-07-17 16:22 | 2026-07-16 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | S - Sale+OE | $36.15 | -28.8K | 36.7K | -44% | -$1.04M |
| DT | 2026-06-24 18:06 | 2026-06-22 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +3,990 | 11.5K | +53% | $0 |
| DT | 2026-06-24 18:06 | 2026-06-22 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | M - OptEx | $41.73 | +2,808 | 14.3K | +25% | +$117.2K |
| DMT | 2026-06-24 18:06 | 2026-06-22+ | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale+OE | $68.25 | -5,004 | 9,259 | -35% | -$341.5K |
| T | 2026-06-16 17:51 | 2026-06-12 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +9,795 | 48.8K | +25% | $0 |
| T | 2026-06-16 17:51 | 2026-06-15 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | S - Sale | $23.11 | -12.1K | 36.7K | -25% | -$279.7K |
| D | 2026-03-12 | 2026-03-10 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | M - OptEx | $27.36 | +8,671 | 16.1K | +116% | +$237.2K |
| D | 2026-03-12 | 2026-03-10 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale+OE | $72.00 | -8,671 | 7,465 | -54% | -$624.3K |
| DM | 2026-03-03 | 2026-02-27 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale+OE | $67.41 | -25.5K | 18.4K | -58% | -$1.72M |
| D | 2026-03-03 | 2026-02-27 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | M - OptEx | $48.45 | +25.5K | 32.9K | +341% | +$1.23M |
| D | 2025-11-14 | 2025-11-12 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale+OE | $66.07 | -25.5K | 7,465 | -77% | -$1.68M |
| D | 2025-11-14 | 2025-11-12 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | M - OptEx | $48.45 | +25.5K | 32.9K | +341% | +$1.23M |
| A | 2025-06-30 | 2021-12-28 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | P - Purchase | $12.68 | +1,542 | 1,542 | New | +$19.6K |
| AI | 2025-06-30 | 2021-12-28 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | P - Purchase | $13.16 | +796 | 2,687 | +42% | +$10.5K |
| MI | 2025-06-30 | 2025-06-26 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale | $44.05 | -2,289 | 2,289 | -50% | -$100.8K |
| M | 2025-06-30 | 2025-06-26 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale | $44.05 | -2,418 | 9,007 | -21% | -$106.5K |
| A | 2025-06-30 | 2021-12-29 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | P - Purchase | $14.24 | +1,752 | 3,294 | +114% | +$24.9K |
| D | 2025-06-24 | 2025-06-20 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +6,589 | 8,353 | +374% | $0 |
| T | 2025-06-23 | 2025-06-18 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | S - Sale | $19.16 | -10.6K | 39.0K | -21% | -$202.5K |
| 2025-06-17 | 2025-06-13 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +12.1K | 49.6K | +32% | $0 | |
| DT | 2025-06-11 | 2025-06-10 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | M - OptEx | $16.75 | +4,292 | 6,056 | +243% | +$71.9K |
| DT | 2025-06-11 | 2025-06-10 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale+OE | $40.00 | -4,292 | 1,764 | -71% | -$171.7K |
| DT | 2025-03-10 | 2025-03-06 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale+OE | $32.58 | -12.9K | 1,764 | -88% | -$419.5K |
| DT | 2025-03-10 | 2025-03-06 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | M - OptEx | $16.75 | +12.9K | 14.6K | +730% | +$215.7K |
| D | 2024-06-20 | 2024-06-18 | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Valantine Hannah | Dir | A - Grant | $0.00 | +22.8K | 22.8K | New | $0 |
| D | 2024-06-18 | 2024-06-14 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +10.6K | 37.5K | +39% | $0 |
| DT | 2024-02-20 | 2024-02-15 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale+OE | $37.75 | -2,915 | 1,764 | -62% | -$110.0K |
| DT | 2024-02-20 | 2024-02-15 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | M - OptEx | $8.45 | +2,915 | 4,679 | +165% | +$24.6K |
| MI | 2024-02-13 | 2021-12-28 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | P - Purchase | $12.96 | +3,433 | 3,433 | New | +$44.5K |
| DT | 2024-01-18 | 2024-01-16 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale+OE | $37.97 | -2,915 | 1,764 | -62% | -$110.7K |
| DT | 2024-01-18 | 2024-01-16 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | M - OptEx | $8.45 | +2,915 | 4,679 | +165% | +$24.6K |
| D | 2023-12-19 | 2023-12-15 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale+OE | $36.12 | -2,915 | 1,764 | -62% | -$105.3K |
| D | 2023-12-19 | 2023-12-15 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | M - OptEx | $8.45 | +2,915 | 4,679 | +165% | +$24.6K |
| D | 2023-11-17 | 2023-11-15 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | M - OptEx | $8.45 | +2,915 | 4,679 | +165% | +$24.6K |
| D | 2023-11-17 | 2023-11-15 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | S - Sale+OE | $30.00 | -2,915 | 1,764 | -62% | -$87.5K |
| D | 2023-06-21 | 2023-06-16 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +18.8K | 26.9K | +234% | $0 |
| 2023-01-09 | 2023-01-06 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +676 | 8,047 | +9% | $0 | |
| 2022-10-04 | 2022-10-04 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +422 | 7,371 | +6% | $0 | |
| 2022-07-06 | 2022-07-01 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +325 | 6,949 | +5% | $0 | |
| D | 2022-06-21 | 2022-06-16 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +4,863 | 6,624 | +276% | $0 |
| 2022-01-03 | 2021-12-29 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Dir | P - Purchase | $14.23 | +1,764 | 1,764 | New | +$25.1K | |
| 2021-10-04 | 2021-10-01 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +131 | 1,761 | +8% | $0 | |
| D | 2021-07-02 | 2021-07-01 | CDNA | CareDx, Inc. | Valantine Hannah | Dir | A - Grant | $0.00 | +1,630 | 1,630 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations